CN111264622A - Infant formula goat milk powder containing N-acetylneuraminic acid - Google Patents
Infant formula goat milk powder containing N-acetylneuraminic acid Download PDFInfo
- Publication number
- CN111264622A CN111264622A CN202010170134.3A CN202010170134A CN111264622A CN 111264622 A CN111264622 A CN 111264622A CN 202010170134 A CN202010170134 A CN 202010170134A CN 111264622 A CN111264622 A CN 111264622A
- Authority
- CN
- China
- Prior art keywords
- parts
- acetylneuraminic acid
- milk powder
- infant formula
- goat milk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 33
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 30
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 title claims abstract description 28
- SQVRNKJHWKZAKO-PFQGKNLYSA-N N-acetyl-beta-neuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-PFQGKNLYSA-N 0.000 title claims abstract description 27
- 235000020251 goat milk Nutrition 0.000 title claims abstract description 18
- 239000002994 raw material Substances 0.000 claims abstract description 12
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 9
- 239000011707 mineral Substances 0.000 claims abstract description 9
- 150000001875 compounds Chemical class 0.000 claims abstract description 8
- 229940088594 vitamin Drugs 0.000 claims abstract description 7
- 229930003231 vitamin Natural products 0.000 claims abstract description 7
- 235000013343 vitamin Nutrition 0.000 claims abstract description 7
- 239000011782 vitamin Substances 0.000 claims abstract description 7
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 6
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 6
- 239000000126 substance Substances 0.000 claims abstract description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000020248 camel milk Nutrition 0.000 claims abstract description 5
- -1 compound vitamin Chemical class 0.000 claims abstract description 4
- 239000005862 Whey Substances 0.000 claims abstract description 3
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 claims abstract description 3
- 229960003080 taurine Drugs 0.000 claims abstract description 3
- 235000021119 whey protein Nutrition 0.000 claims abstract description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 14
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 12
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 12
- 235000010755 mineral Nutrition 0.000 claims description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 7
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 7
- 229960000304 folic acid Drugs 0.000 claims description 7
- 235000019152 folic acid Nutrition 0.000 claims description 7
- 239000011724 folic acid Substances 0.000 claims description 7
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 7
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 6
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 6
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 6
- 239000002211 L-ascorbic acid Substances 0.000 claims description 6
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 6
- 229960005070 ascorbic acid Drugs 0.000 claims description 6
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 6
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 6
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 claims description 6
- 239000011706 ferric diphosphate Substances 0.000 claims description 6
- 235000007144 ferric diphosphate Nutrition 0.000 claims description 6
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 claims description 6
- 229940036404 ferric pyrophosphate Drugs 0.000 claims description 6
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 6
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 6
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 6
- 229960000342 retinol acetate Drugs 0.000 claims description 6
- 239000011770 retinyl acetate Substances 0.000 claims description 6
- 235000019173 retinyl acetate Nutrition 0.000 claims description 6
- 229960001471 sodium selenite Drugs 0.000 claims description 6
- 239000011781 sodium selenite Substances 0.000 claims description 6
- 235000015921 sodium selenite Nutrition 0.000 claims description 6
- 239000011647 vitamin D3 Substances 0.000 claims description 6
- 235000005282 vitamin D3 Nutrition 0.000 claims description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 6
- 229940021056 vitamin d3 Drugs 0.000 claims description 6
- 239000011787 zinc oxide Substances 0.000 claims description 6
- 229960003563 calcium carbonate Drugs 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 229960001296 zinc oxide Drugs 0.000 claims description 2
- 235000014692 zinc oxide Nutrition 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 10
- 230000036039 immunity Effects 0.000 abstract description 9
- 230000035764 nutrition Effects 0.000 abstract description 8
- 241000700605 Viruses Species 0.000 abstract description 6
- 230000006870 function Effects 0.000 abstract description 5
- 239000000203 mixture Substances 0.000 abstract description 4
- 235000013305 food Nutrition 0.000 abstract description 3
- 235000013336 milk Nutrition 0.000 description 9
- 210000004080 milk Anatomy 0.000 description 9
- 239000008267 milk Substances 0.000 description 9
- 235000020256 human milk Nutrition 0.000 description 8
- 210000004251 human milk Anatomy 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 3
- 235000020247 cow milk Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000209149 Zea Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- SQVRNKJHWKZAKO-LUWBGTNYSA-N N-acetylneuraminic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)CC(O)(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-LUWBGTNYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 210000003022 colostrum Anatomy 0.000 description 1
- 235000021277 colostrum Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229940060155 neuac Drugs 0.000 description 1
- CERZMXAJYMMUDR-UHFFFAOYSA-N neuraminic acid Natural products NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO CERZMXAJYMMUDR-UHFFFAOYSA-N 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 229940091258 selenium supplement Drugs 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Dairy Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an infant formula goat milk powder containing N-acetylneuraminic acid, which is prepared from the following raw materials in parts by weight: 90-100 parts of whole camel milk powder, 1-3 parts of desalted whey powder, 2-7 parts of isomaltooligosaccharide, 2-6 parts of concentrated whey protein powder, 0.005-0.05 part of N-acetylneuraminic acid, 1-3 parts of compound vitamin, 1-2 parts of compound mineral substance and 0.0004-0.0006 part of taurine. The N-acetylneuraminic acid health-care food has reasonable formula composition and comprehensive nutrition, and has the health-care functions of resisting viruses, improving the immunity and the like brought by the N-acetylneuraminic acid.
Description
Technical Field
The invention relates to the technical field of food formulas, in particular to infant formula goat milk powder containing N-acetylneuraminic acid.
Background
Infants are a special group whose most desirable food is breast milk, which not only provides a source of nutrition, but also contains biological components that promote the normal growth and development of the infant. However, with the continuous development and progress of society, some women cannot breast-feed due to physical and work reasons, and buy formula powder to feed infants. The infant formula milk powder is used as a breast milk substitute, and aims to simulate the nutritional ingredients and functions of breast milk so that the growth and development conditions of non-breast-fed infants and pure-breast-fed infants are consistent. The research and production of infant formula milk powder in China are late, milk-based formula milk powder is mainly used at present, and other types of infant formula milk powder are less. Cow milk is always considered as a good choice of infant formula milk base materials due to rich nutrition and wide sources, but in recent years, due to the fact that allergy cases caused by cow milk infant formula milk powder are increased, people have more and more cognizance on concepts such as nutrition, health and the like, goat milk with rich nutritional value and low sensitization rate and formula milk powder taking goat milk as a main raw material are widely concerned. In addition, the immunity of infants in early stage is particularly poor, the ability of protecting against bacteria and viruses is poor, so that the infants are frequently sick, and the breast milk is used for nursing under normal conditions, so that the infant formula milk powder is completely used as a breast milk substitute, and the current research problem on how to improve the immunity of the infants is solved.
Research shows that N-acetylneuraminic acid is called SA, NeuAc or NANA for short, is commonly called sialic acid or cubilose acid, and has a chemical molecular formula of C11H19NO9It is widely derived from breast milk and milk products, including human milk, cow milk, goat milk, etc., and has the highest content in breast milk colostrum. The industrial production process of the corn steep liquor is characterized in that food-grade glucose and corn steep liquor are taken as raw materials and are prepared by processes of fermentation, filtration, sterilization, hydrolysis, purification and the like of Escherichia coli (strain number SA-8). The N-acetylneuraminic acid can be combined with bacteria and viruses to achieve the effects of inhibiting and resisting through a certain mechanism. Meanwhile, the N-acetylneuraminic acid can regulate the anti-inflammatory activity of IgG, so that the effect of improving the immunity is achieved. N-acetylneuraminic acid has the functions of resisting bacteria and viruses and improving immunity, and is very important for human bodies. At present, no technical scheme related to infant formula goat milk powder added with N-acetylneuraminic acid is disclosed.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides the infant formula goat milk powder containing N-acetylneuraminic acid, which is beneficial to digestion and absorption, reasonable in formula composition, lower in allergenicity, comprehensive in nutrition and capable of improving immunity.
In order to realize the purpose of the invention, the following technical scheme is adopted:
an infant formula goat milk powder containing N-acetylneuraminic acid is composed of the following raw materials in parts by weight: 90-100 parts of whole camel milk powder, 1-3 parts of desalted whey powder, 2-7 parts of isomaltooligosaccharide, 2-6 parts of concentrated whey protein powder, 0.005-0.05 part of N-acetylneuraminic acid, 1-3 parts of compound vitamin, 1-2 parts of compound mineral substance and 0.0004-0.0006 part of taurine.
Preferably, the compound vitamin is prepared from retinyl acetate, cholecalciferol, dl- α -tocopheryl acetate, pyridoxine hydrochloride, folic acid and L-ascorbic acid.
Preferably, the vitamin complex is prepared by mixing 0.5-0.8 part of retinyl acetate, 1.6-1.8 parts of cholecalciferol, 0.7-0.9 part of dl- α -tocopheryl acetate, 0.6-0.9 part of pyridoxine hydrochloride, 0.9-1.1 part of folic acid and 0.35-0.45 part of L-ascorbic acid.
Preferably, the composite mineral is prepared from the following raw materials: ferric pyrophosphate, zinc oxide, sodium selenite and calcium carbonate.
Preferably, the compound mineral is prepared by mixing 0.4-0.6 part of ferric pyrophosphate, 0.3-0.5 part of zinc oxide, 0.25-0.45 part of sodium selenite and 0.9-1.1 part of calcium carbonate.
Compared with the prior art, the camel milk is used as a main raw material, and the N-acetylneuraminic acid and other vitamin A, vitamin D, vitamin E, vitamin B6, vitamin C, folic acid, calcium, iron, zinc and selenium which are necessary for human bodies are added, so that the camel milk has comprehensive formula nutrition, and can enhance the immunity of infants and strengthen bones.
Detailed Description
The technical solution of the present invention is further illustrated by the following examples.
Example 1
The infant formula goat milk powder containing N-acetylneuraminic acid is prepared by mixing the following raw materials in parts by weight:
wherein the vitamin complex is prepared by mixing 0.5-0.8 part of retinyl acetate, 1.6-1.8 parts of cholecalciferol, 0.7-0.9 part of dl- α -tocopheryl acetate, 0.6-0.9 part of pyridoxine hydrochloride, 0.9-1.1 part of folic acid and 0.35-0.45 part of L-ascorbic acid.
Wherein the compound mineral substance is formed by mixing 0.4-0.6 part of ferric pyrophosphate, 0.3-0.5 part of zinc oxide, 0.25-0.45 part of sodium selenite and 0.9-1.1 part of calcium carbonate.
The milk powder prepared by mixing the raw materials has reasonable formula composition and comprehensive nutrition, and has the health-care functions of resisting virus, improving immunity and the like brought by N-acetylneuraminic acid.
Example 2
The infant formula goat milk powder containing N-acetylneuraminic acid is prepared by mixing the following raw materials in parts by weight:
wherein the vitamin complex is prepared by mixing 0.5-0.8 part of retinyl acetate, 1.6-1.8 parts of cholecalciferol, 0.7-0.9 part of dl- α -tocopheryl acetate, 0.6-0.9 part of pyridoxine hydrochloride, 0.9-1.1 part of folic acid and 0.35-0.45 part of L-ascorbic acid.
Wherein the compound mineral substance is formed by mixing 0.4-0.6 part of ferric pyrophosphate, 0.3-0.5 part of zinc oxide, 0.25-0.45 part of sodium selenite and 0.9-1.1 part of calcium carbonate.
The goat milk powder prepared by mixing the raw materials has reasonable formula composition and comprehensive nutrition, and has the health-care functions of resisting viruses, improving immunity and the like of the N-acetylneuraminic acid.
Claims (5)
1. An infant formula goat milk powder containing N-acetylneuraminic acid is composed of the following raw materials in parts by weight: 90-100 parts of whole camel milk powder, 1-3 parts of desalted whey powder, 2-7 parts of isomaltooligosaccharide, 2-6 parts of concentrated whey protein powder, 0.005-0.05 part of N-acetylneuraminic acid, 1-3 parts of compound vitamin, 1-2 parts of compound mineral substance and 0.0004-0.0006 part of taurine.
2. The infant formula goat milk powder containing N-acetylneuraminic acid as claimed in claim 1, wherein the multivitamins are prepared from retinyl acetate, cholecalciferol, dl- α -tocopheryl acetate, pyridoxine hydrochloride, folic acid, L-ascorbic acid.
3. The infant formula goat milk powder containing N-acetylneuraminic acid according to claim 1 or 2, wherein the multivitamins are prepared by mixing 0.5-0.8 parts of retinyl acetate, 1.6-1.8 parts of cholecalciferol, 0.7-0.9 parts of dl- α -tocopheryl acetate, 0.6-0.9 parts of pyridoxine hydrochloride, 0.9-1.1 parts of folic acid and 0.35-0.45 parts of L-ascorbic acid.
4. The infant formula goat milk powder containing N-acetylneuraminic acid as claimed in claim 1, wherein the compound mineral is prepared from the following raw materials: ferric pyrophosphate, zinc oxide, sodium selenite and calcium carbonate.
5. The infant formula goat milk powder containing N-acetylneuraminic acid as claimed in claim 1 or 4, wherein the compound mineral is prepared by mixing 0.4-0.6 part of ferric pyrophosphate, 0.3-0.5 part of zinc oxide, 0.25-0.45 part of sodium selenite and 0.9-1.1 part of calcium carbonate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010170134.3A CN111264622A (en) | 2020-03-12 | 2020-03-12 | Infant formula goat milk powder containing N-acetylneuraminic acid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010170134.3A CN111264622A (en) | 2020-03-12 | 2020-03-12 | Infant formula goat milk powder containing N-acetylneuraminic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111264622A true CN111264622A (en) | 2020-06-12 |
Family
ID=70992401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010170134.3A Pending CN111264622A (en) | 2020-03-12 | 2020-03-12 | Infant formula goat milk powder containing N-acetylneuraminic acid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111264622A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112006103A (en) * | 2020-09-21 | 2020-12-01 | 西安小天使健康科技研究院有限公司 | Multifunctional nutritional camel milk powder and preparation method thereof |
| WO2021068994A1 (en) * | 2019-10-10 | 2021-04-15 | 杭州烜烁网络科技有限公司 | Milk powder containing sialic acid and camel milk |
| CN113455548A (en) * | 2021-07-05 | 2021-10-01 | 西安百跃羊乳集团有限公司 | Child formula goat milk powder capable of preventing germ invasion and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109007037A (en) * | 2018-10-16 | 2018-12-18 | 北京斯利安药业有限公司 | A kind of composition and products thereof enhancing infant immunity and application |
| CN110063372A (en) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | A kind of infant formula goat milk powder and its production method |
| CN110063371A (en) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | A kind of infant formula goat milk powder and its production method |
| CN110353049A (en) * | 2019-08-29 | 2019-10-22 | 刘晓丽 | A kind of camel milk formula and preparation method thereof |
-
2020
- 2020-03-12 CN CN202010170134.3A patent/CN111264622A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110063372A (en) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | A kind of infant formula goat milk powder and its production method |
| CN110063371A (en) * | 2018-01-23 | 2019-07-30 | 天津澳斯乳业有限公司 | A kind of infant formula goat milk powder and its production method |
| CN109007037A (en) * | 2018-10-16 | 2018-12-18 | 北京斯利安药业有限公司 | A kind of composition and products thereof enhancing infant immunity and application |
| CN110353049A (en) * | 2019-08-29 | 2019-10-22 | 刘晓丽 | A kind of camel milk formula and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 蒋林等: "《解开燕窝密码》", 31 January 2014, 广东省地图出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021068994A1 (en) * | 2019-10-10 | 2021-04-15 | 杭州烜烁网络科技有限公司 | Milk powder containing sialic acid and camel milk |
| CN112006103A (en) * | 2020-09-21 | 2020-12-01 | 西安小天使健康科技研究院有限公司 | Multifunctional nutritional camel milk powder and preparation method thereof |
| CN113455548A (en) * | 2021-07-05 | 2021-10-01 | 西安百跃羊乳集团有限公司 | Child formula goat milk powder capable of preventing germ invasion and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111264622A (en) | Infant formula goat milk powder containing N-acetylneuraminic acid | |
| CN102038041B (en) | Mineral substance formula milk powder for infants | |
| CN100391353C (en) | Formula milk powder for babies | |
| WO2021068994A1 (en) | Milk powder containing sialic acid and camel milk | |
| CN103070241B (en) | Infant-formula goat milk powder of pure goat milk protein and preparation method thereof | |
| CN102174073A (en) | Oyster protein peptide and zinc chelate and method for preparing same | |
| CN111543496A (en) | Milk powder for helping children to grow in height and skeleton | |
| CN112056403A (en) | Novel formula of children's milk powder for promoting growth of high-blood fat | |
| CN103168839A (en) | Preparation process of infant formula milk powder | |
| CN111067104A (en) | Composite probiotic infant formula milk powder and preparation method thereof | |
| CN112167360A (en) | Low-sensitization infant formula goat milk powder | |
| CN104489101A (en) | Infant milk powder rich in osteopontin | |
| CN102771563A (en) | Selenium-enriched milk product and production method thereof | |
| CN102405975B (en) | Liquid dairy product for improving child anorexia and preparation method thereof | |
| CN1067223C (en) | Lactose-containing food composition for infants | |
| CN112075504A (en) | Infant formula milk powder for enhancing immunity | |
| CN111642566A (en) | Goat milk powder beneficial to children's height and intelligence development | |
| CN1300549A (en) | Formula and process for preparing milk powder containing iron and protein for baby | |
| CN1107656A (en) | Milk powder simulating breast milk for infants | |
| CN1656904A (en) | Formulated milk powder for baby and its preparation method | |
| CN103461491A (en) | Novel yogurt production and preparation process | |
| CN113973926A (en) | Infant series yak milk formula milk powder and preparation method thereof | |
| CN102511815A (en) | Selenium-enriched oral solution and preparation method thereof | |
| CN110973596A (en) | Infant rice flour rich in easily-absorbed zinc trace element nutrition enhancer | |
| Mahmood | Zinc levels among preterm infants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 310000 room 1103-04, building 2, No. 371, Mingxing Road, Xiaoshan Economic and Technological Development Zone, Xiaoshan District, Hangzhou City, Zhejiang Province Applicant after: Hangzhou jishuo Network Technology Co.,Ltd. Address before: 310000 room 1103-04, building 2, No. 371, Mingxing Road, Xiaoshan Economic and Technological Development Zone, Xiaoshan District, Hangzhou City, Zhejiang Province Applicant before: Hangzhou Lianxing Trading Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200612 |
|
| RJ01 | Rejection of invention patent application after publication |